PATH, Patient Access To Health
PATH, Patient Access to Health by Biotrial, is a dedicated clinical unit designed to accelerate patient access to innovative treatments, while ensuring the highest standards of clinical excellence.
PATH, Patient Access to Health by Biotrial, is a dedicated clinical unit designed to accelerate patient access to innovative treatments, while ensuring the highest standards of clinical excellence.

Fully operated by Biotrial, this solution centralizes patient management in a controlled environment, supported by stable, highy specialized clinical teams. By combining operational efficiency, robust data integrity, and continuous safety oversight, PATH delivers a seamless, reliable connection with patients.
Two CPU, based in Rennes (France) and New Jersey (USA), offer a total of 260 beds with state-of-the-art equipment to support exploratory and confirmatory clinical trials through a fully integrated solution.
To summarize, PATH is a fully coordinated ecosystem designed to enhance both clinical performance and patient experience.

PATH was designed to address today’s most critical clinical development challenges.
A clinical journey designed around care, comfort, and safety.
PATH transforms participation in a clinical trial into a structured, supportive, and reassuring experience.
